2/ First authors: Evey Zheng and Dr. Chung-Hsi Wang
Senior author: Dr. Naoto Hirano
#CART #CancerResearch #Immunotherapy #Leukemia
--
@uhn.ca @aacrjournals.bsky.social

2/ First authors: Evey Zheng and Dr. Chung-Hsi Wang
Senior author: Dr. Naoto Hirano
#CART #CancerResearch #Immunotherapy #Leukemia
--
@uhn.ca @aacrjournals.bsky.social
💊 Distinct treatment responses reflect AML heterogeneity
Congratulations to everyone involved, and many thanks to all our collaborators! 👏
Interested in working with these models? Get in touch!
#AML #Leukemia #CancerResearch #PDX #TranslationalResearch
Register for free at cancergrace.org
📅 October 10, 2026
⏰ 11:00 a.m. ET
💻 Virtual and free event
#BloodCancers #Leukemia #Lymphoma #BloodCancer #MultipleMyeloma
📢Interested in #CancerMetabolism and #leukemia using mouse models in vivo? Come join us!! We're looking for a #postdoc to help us drive one of our multiple currently funded projects! Friends & colleagues, please RT!
👇👇👇
jobs.rutgers.edu/postings/276...
#Dr.AliceStewart #xrays #leukemia #epidemiology
Blood-forming stem cells are surprisingly flexible during fetal development. This may help explain why some childhood leukemias arise early in life.
New research from Lund University:
www.stemcellcenter.lu.se/article/bloo...
#StemCells #DevelopmentalBiology #Hematopoiesis #Leukemia #Research
BLOOD CANCERS: If you need some encouragement and #peersupport, look no further. Drop into our #BloodCancer support group TONIGHT 8pm ET / 5pm PT
➡️https://www.gotomeet.me/ancanschmier
#CLL #leukemia #lymphoma #multiplemyeloma #nonhodgkinslymphoma
Deep, durable responses in relapsed/refractory B-ALL: dose-dense mini-CVD plus inotuzumab ozogamicin and blinatumomab shows promising results for a hard-to-treat population.
Read more: sohoinsider.com/news/dose-de...
#HemOnc #Leukemia
Not all blood cancers look alike. #Leukemia and #myeloma can have different signs and symptoms. Knowing what to look for can help you know when to talk with your doctor. Learn more at knowmyeloma.org. #KnowMyeloma Thank you to GSK for helping us share the differences.
A nationwide study shows that #genetic testing can identify germline predisposition underlying childhood #leukemia. The findings, published in @natcomms.nature.com, could help enable more personalized treatment and long-term follow-up 🧪
🧠 CNS prophylaxis remains essential in ALL, especially as therapy becomes chemo-attenuated or chemo-free. Blinatumomab/inotuzumab do not replace CNS-directed therapy. Modern regimens often use 12–15 IT treatments, tailored to regimen and risk. #ALL #Leukemia #Hematology
Epigenetics Update - 5-Azacytosine induces cytotoxicity via 5-methylcytosine depletion on chromatin-associated RNA in leukemia u.epigenome.us/MBe0Tv0n
Mingjiang Xu and Chuan He in Molecular Cell
#Epigenetics #Chromatin #caRNAs #Leukemia
---
Cancer, immunology, and aging; epigenometech.com
What is the difference between acute and chronic #leukemia? This past Saturday, Mercy medical oncologist Dr. Sandy Kotiah spoke with #WBAL-TV11 reporter/anchor Jennifer Franciotti live via Zoom on “The Woman’s Doctor”.
www.wbaltv.com/article/merc...
@wbaltv11.bsky.social
Fourth bone marrow biopsy done. My hip must be like swiss cheese now! #cancer #nomoreneedles #leukemia
On September 16th, 2009: #MaryTravers, American folk #singer (#PeterPaulAndMary - "Puff" (The Magic Dragon)"; "Leaving On A Jet Plane"), died of #leukemia at 72.
#RIP 🪽🥀
Mixed lineage leukemia (MLL) rearrangements drive approximately 10% of acute leukemias.
These findings from Dr. Wei Du's lab identify NHEJ blockade as a promising targeted therapeutic strategy for high-risk MLL-rearranged #leukemia: https://go.nature.com/4qSnqbC